Screener
Medicus Pharma
MDCXMedicus Pharma Ltd. is a clinical-stage, multi-strategy biotechnology company focused on developing novel therapeutic assets through Phase 2 proof-of-concept.
$6.6M-85.9%
Earnings
Next report
Nov 13, 2026 (in a month)EPS estimate-$0.17
Competitors
By market cap
By revenue growth
Profile
Medicus Pharma Ltd. is a clinical-stage, multi-strategy biotechnology company focused on developing novel therapeutic assets through Phase 2 proof-of-concept. The company utilizes a capital-efficient model to advance disruptive medical technologies, primarily targeting non-melanoma skin cancers and advanced prostate cancer, with the intent to out-license or partner with established pharmaceutical firms for late-stage development.
Competitive position
A clinical-stage developer of niche therapeutic delivery systems and hormone therapies targeting multi-billion dollar markets in dermatology and urology.
GeographiesUnited States, United Kingdom, United Arab Emirates
Customer segmentsPharmaceutical Companies, Healthcare Providers
Business modelR&D, IP Licensing, Clinical Stage Biotech
SuppliersAcademic Research Institutions, Contract Manufacturing Organizations, Active Pharmaceutical Ingredient Suppliers
CustomersGlobal Pharmaceutical Companies, Specialty Healthcare Providers, Clinical Research Organizations
CountryCanada
Listed2023
CEORaza Bokhari
SectorHealthcare
IndustryBiotechnology
Websitemedicuspharma.com
FilingsSEC EDGAR
FAQ
- What is Medicus Pharma's market cap?
- Medicus Pharma (MDCX) has a market capitalization of $6.6M and trades on XNAS.
- Who are Medicus Pharma's competitors?
- Medicus Pharma's key competitors include CytomX Therapeutics, Inc., Azitra Inc, Soligenix, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
- Who does Medicus Pharma partner with?
- Medicus Pharma's notable partners include University of Pittsburgh, Helix Nanotechnologies, Inc., Gorlin Syndrome Alliance, and others.
- What subsidiaries does Medicus Pharma have?
- Medicus Pharma's subsidiaries include SkinJect Inc., Antev Ltd..
- Where is Medicus Pharma headquartered?
- Medicus Pharma is headquartered in Canada. It has been publicly traded since 2023.